loader
Please Wait
Applying Filters...
menu
    • menu

    List of Written Confirmation(s) issued for Cefdinir Active Pharmaceutical Ingredient (API)

    Client Email Product
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Cefdinir

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 300Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    29/04/2020 Aurobindo Pharma Limited
    India
    		 M/s. Aurobindo Pharma Ltd.,  WC-0120 Cefdinir (IH/USP) 2022-07-15 2025-07-02 Unit-1, Sy. No. 388 & 389, Borpatla (V), Hatnoora (M), Medak (Dist).502 296 A.P. 
    01/01/2018 Covalent Laboratories Private Limited
    India
    		 M/s. Covalent Laboratories Pvt. Ltd., WC-0190 Cefdinir (JP/USP/CP) 2019-09-03 2022-09-03 Sy.No.374, Gundla Machanoor Village, Hathnoor Mandal, Medak District-502 296, AP